SCHEMBL12840512

SCHEMBL12840512

CCCc1nc2c(nc1NC(=O)c1ccccc1)CCc1ccccc1-2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.49
CYP3A4 P08684 4/20 0.49
CYP2C19 P33261 3/20 0.49
GAA P10253 3/20 0.49
L3MBTL1 Q9Y468 4/20 0.45
KDM4E B2RXH2 9/20 0.41
ALDH1A1 P00352 7/20 0.41
HPGD P15428 4/20 0.41
CYP2C9 P11712 2/20 0.41
HTT P42858 2/20 0.41
CYP2D6 P10635 1/20 0.41
MAPT P10636 3/20 0.41
LMNA P02545 2/20 0.41
POLB P06746 2/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12839118 0.91 CYP1A2 (0.51) CYP1A2CYP3A4CYP2C19GAAL3MBTL1
SCHEMBL12838589 0.89 CYP1A2 (0.52) CYP1A2CYP3A4CYP2C19GAAL3MBTL1
SCHEMBL12839390 0.89 POLB (0.48) CYP1A2CYP3A4CYP2C19GAAL3MBTL1
SCHEMBL12840126 0.89 HCAR2 (0.42) CYP1A2CYP3A4CYP2C19GAAL3MBTL1
SCHEMBL12838694 0.88 L3MBTL1 (0.41) CYP1A2CYP3A4CYP2C19GAAL3MBTL1
SCHEMBL12840664 0.88 L3MBTL1 (0.41) CYP1A2CYP3A4CYP2C19GAAL3MBTL1
SCHEMBL12839413 0.86 TSHR (0.42) CYP1A2CYP3A4CYP2C19GAAL3MBTL1
SCHEMBL12838733 0.86 MAPT (0.52) CYP1A2CYP3A4CYP2C19L3MBTL1KDM4E
SCHEMBL12839420 0.86 CYP1A2 (0.48) CYP1A2CYP3A4CYP2C19GAAL3MBTL1
SCHEMBL12840102 0.85 CYP1A2 (0.50) CYP1A2CYP3A4CYP2C19GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110070656-A1 Fluorescent Proteins JNC CORPORATION (JP) 2011-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110070656-A1 Fluorescent Proteins CACYBP, CHLSN, LCP2 CYP1A2 4017/4885CYP3A4 1812/4885CYP2C19 4355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.